|
⚲
|
| Keyboard |
| CeleCor Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001705381 |
| Sale | 2026-06-09 (15.0 M Offered, 11.9 M Sold) |
| Fund | |
| Phone | 8587779750 |
| Address | 1155 Camino del Mar del Mar, CA 92014 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-09 (D) |
| Exemption | 506(b) |
| Remaining | $3,143,675 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Peter Finn | Executive Officer | |
| Jack Lief | Director | |
| Andreas Ritzi | Director | |
| Robert Hillman PhD | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Triple Frond Partners LLC
✚
|
CA | |
|
Conviction Partners LLC
✚
|
CA | |
|
Bel Air Investment Advisors LLC
✚
|
CA | |
|
The Donerail Group LP
✚
|
CA | |
|
Bond Capital Management LP
✚
|
CA | |
|
Capital Research Global Investors
✚
|
CA | |
|
Menlo Ventures Management LP
✚
|
CA | |
|
Bristol Capital Advisors LLC
✚
|
CA | |
|
Almaz Capital Management Ltd
✚
|
CA | |
|
Avante Capital Partners LP
✚
|
CA |